呼吸器センター内科

肺がん

びまん性肺疾患

呼吸器感染症

疾患別入院患者数

Tsunoda S, Mitsumura T, Kato T, Nakahama H, Nei Y, Hanada S, Miyamoto A, Uruga H, Fujii T, Kobayashi Y, Tamaoka M. Cryobiopsy for diagnosing acute fibrinous and organizing pneumonia during breast cancer treatment: A case report. Exp Ther Med. 29(6):115, 2025. doi: 10.3892/etm.2025.12865

Okuda R*, Ogura T, Hisata S, Baba T, Kondoh Y, Suda T, Johkoh T, Iwasawa T, Tomioka H, Bando M, Azuma A, Inoue Y, Ishikawa N, Arai N, Takihara T, Hamaguchi M, Arai T, Nakamura Y, Miyamoto A, Tomii K, Miyazaki Y, Chiba H, Ishii H, Hamada N, Terasaki Y, Fukuoka J, Sakai F, Egashira R, Fujimoto K, Sumikawa H, Suzuki T, Sakamoto S, Nishioka Y, Hattori N, Hashimoto N, Morita S, Ichihara N, Miyata H, Hagiwara K, Kobayashi K, Nukiwa T; JIPS registry collaborators: Prognostic prediction for newly diagnosed patients with idiopathic interstitial pneumonia: JIPS Registry (NEJ030). Respir Investig. 2025 May;63(3):365-372. doi: 10.1016/j.resinv.2025.02.009. Epub 2025 Mar 17.

＊Kanagawa Cardiovascular and Respiratory Center

Komatsuzaki K*, Otani Y, Kageshima H, Sekino Y, Suzuki Y, Ugajin T, Tamaoka M, Yorozu P, Hanazawa R, Hirakawa A, Murakami D, Miyazaki Y: Safety of local nasal immunotherapy using hypoallergenic birch pollen ointment in patients with pollen-food allergy syndrome: A preliminary study of five cases.

Allergol Int. 2025 Apr;74(2):336-339. doi: 10.1016/j.alit.2024.10.006. Epub 2024 Nov 12.

*Institute of Science Tokyo

Koyauchi T*, Fujisawa T, Miyashita M, Mori M, Morita T, Yazawa S, Akiyama N, Hagimoto S, Matsuda Y, Tachikawa R, Yasui H, Suzuki M, Asai Y, Ono M, Kimura Y, Ohkouchi S, Tanino Y, Sugino K, Tateishi T, Kato M, Miyamoto A, Saito Y, Sakamoto S, Kono M, Yokomura K, Imokawa S, Sakamoto K, Waseda Y, Handa T, Hattori N, Anabuki K, Yatera K, Shundo Y, Hoshino T, Sakamoto N, Kondoh Y, Tomioka H, Tomii K, Inoue Y, Suda T: Prognostic Awareness and Knowledge of Acute Exacerbation in Patients Dying with Interstitial Lung Disease: A Nationwide Survey. Ann Am Thorac Soc. 2025 Mar;22(3):395-402. doi: 10.1513/AnnalsATS.202405-495OC.

PMID: 39513985

*Seirei Mikatahara Hospital,

Asao T*, Shukuya T, Uemura K, Kitadai R, Yamamoto G, Mouri A, Tamaoka M, Imai R, Tsukita Y, Isobe K, Watanabe S, Kamimura M, Morita R, Kudo K, Inomata M, Tateishi K, Kakinuma K, Yoshioka H, Namba Y, Sumiyoshi I, Nakagawa T, Watanabe K, Kobayashi K, Takahashi K: Risk and survival of patients with non-small cell lung cancer and pre-existing autoimmune disorders receiving immune checkpoint blockade therapy: Survival analysis with inverse probability weighting from a nationwide, multi-institutional, retrospective study (NEJ047).Lung Cancer. 194:107894. 2024

doi: 10.1016/j.lungcan.2024.107894. Epub 2024 Jul 14.

*Juntendo University Graduate School of Medicine

Hanada S, Wajima T, Takata M, Morozumi M, Shoji M, Iwata S, Ubukata K: Clinical manifestations and biomarkers to predict mortality risk in adults with invasive Streptococcus dysgalactiae subsp. equisimilis infections. Eur J Clin Microbiol Infect Dis. 43(8):1609-1619.2024　doi: 10.1007/s10096-024-04861-4. Epub 2024 Jun 7.

Shimada S*, Yamaguchi T, Mikoshiba S, Sato K, Mitsumura T, Komori K, Yamana T, Iijima Y, Sakakibara R, Shibata S, Honda T, Shirai T, Okamoto T, Furusawa H, Tateishi T, Miyazaki Y: Relapsing bronchopneumonia due to community-associated methicillin-resistant Staphylococcus aureus: a case report. BMC Infect Dis. 2024 Apr 4;24(1):374. doi: 10.1186/s12879-024-09268-2.

*Department of Respiratory Medicine, Tokyo Medical and Dental University

Bando M*, Homma S, Date H, Kishi K, Yamauchi H, Sakamoto S, Miyamoto A, Goto Y, Nakayama T, Azuma A, Kondoh Y, Johkoh T, Nishioka Y, Fukuoka J, Miyazaki Y, Yoshino I, Suda T; Ministry of Health, Labour and Welfare, the Study Group on Diffuse Pulmonary Disorders, Scientific Research/Research on Intractable Diseases, and Japanese Respiratory Society: Japanese guidelines for the treatment of idiopathic pulmonary fibrosis 2023:Revised edition. Respir Investig. 62(3):402-418,2024 doi: 10.1016/j.resinv.2024.02.014. Epub 2024 Mar 14.

* Jichi Medical University.

Isobe T*, Miyamoto A, Waseda Y, Tsubata Y, Otsuka M, Ishida M, Horimasu Y, Nureki S Hamaguchi S, Kurimoto N,Takahashi H, Ishii H and Multicenter Research Group for the Future of BAL: Nationwide Questionnaire-based Survey on Methods for Performing Bronchoalveolar Lavage. Respir Endosc 2(3): 141-147,2024

* Shimane University Faculty of Medicine

Michimae H*, Emura T, Miyamoto A, Kishi K: Bayesian parametric estimation based on left-truncated competing risks data under bivariate Clayton copula models. J Appl Stat. 51(13):2690-2708, 2024

doi: 10.1080/02664763.2024.2315458. eCollection 2024.

* Kitasato University

Kubota N*, Okamoto T, Shimada S, Yamana T, Iijima Y, Sakakibara R, Shibata S, Honda T, Mitsumura T, Shirai T, Furusawa H, Tateishi T, Adachi T, Kirimura S, Miyazaki Y: Solitary Pure Ground-glass Opacity Suspected of Being the Initial Presentation of Nonfibrotic Hypersensitivity Pneumonitis. Intern Med. 2024 Sep 15;63(18):2543-2546.

doi: 10.2169/internalmedicine.3030-23. Epub 2024 Feb 12.

*Department of Respiratory Medicine, Tokyo Medical and Dental University

Miyamoto A, Michimae H, Nakahara Y, Akagawa S, Nakagawa K, Minegishi Y, Ogura T, Hontsu S, Date H, Takahashi K, Homma S, Kishi K; Investigators Group for Lung Cancer and IIP:Acute exacerbation predicting poor outcomes in idiopathic interstitial pneumonia and advanced lung cancer patients undergoing cytotoxic chemotherapy. Sci Rep. 14(1):10162,2024 doi: 10.1038/s41598-024-60833-w.

Komatsuzaki K*, Kageshima H, Sekino Y, Suzuki Y, Ugajin T, Tamaoka M, Hanazawa R, Hirakawa A, Miyazaki Y: Local nasal immunotherapy with birch pollen-galactomannan conjugate-containing ointment in mice and humans.Allergol Int. 73(2):290-301.2024 doi: 10.1016/j.alit.2023.10.007. Epub 2023 Nov 18. PMID: 37981502

*Tokyo Medical and Dental University

森口修平, 花田豪郎, 村瀬享子, 中濱洋, 宮本篤, 玉岡明洋:癌性腹膜炎との鑑別に苦慮したT‐SPOT.TB陰性の結核性腹膜炎の1例.結核､99(5):139-143,2024

村瀬享子, 花田豪郎, 森口修平, 中濱洋, 宮本篤, 高谷久史, 玉岡明洋:多彩な中枢神経結核の病態を呈した粟粒結核の1例.結核､99(5):133-137,2024

Miyamoto A, Michimae H, Nakahara Y, Akagawa S, Nakagawa K, Minegishi Y, Ogura T, Hontsu S, Date H, Takahashi K, Homma S, Kishi K; Investigators Group for Lung Cancer and IIP: Chemotherapy versus best supportive care in advanced lung cancer and idiopathic interstitial pneumonias: A retrospective multi-centre cohort study. Respir Investig, 61(2):284-295,2023　doi:10.1016/j.resinv.2022.10.009. Epub 2022 Dec 7. PMID: 36496345.

Ikeda M*, Okugawa S, Kashiwabara K, Moritoyo T, Kanno Y, Jubishi D, Hashimoto H, Okamoto K, Tsushima K, Uchida Y, Mitsumura T, Igari H, Tsutsumi T, Araoka H, Yatera K, Yamamoto Y, Nakamura Y, Otani A, Yamashita M, Wakimoto Y, Shinohara T, Adachi-Katayama M, Oyabu T, Kanematsu A, Harada S, Takeshita Y, Nakano Y, Miyazaki Y, Sakao S, Saito M, Ogura S, Yamasaki K, Kawasuji H, Hataji O, Inoue J, Seto Y, Moriya K: Multicenter, single-blind, randomized controlled study of the efficacy and safety of favipiravir and nafamostat mesilate in patients with COVID-19 pneumonia.　 Int J Infect Dis. 2023 Mar;128:355-363,2023　doi: 10.1016/j.ijid.2022.12.039.

* The University of Tokyo Hospital

Okada K*, Sakakibara R, Honda T, Mitsumura T, Shibata S, Shirai T, Okamoto T, Furusawa H, Tateishi T, Miyazaki Y: Tolerability of sotorasib for KRAS positive lung adenocarcinoma patient with pre-existing interstitial pneumonia; A case report. Respir Med Case Rep, 46:101929,2023

*Tokyo Medical and Dental University

Komatsuzaki K*, Kageshima H, Sekino Y, Suzuki Y, Ugajin T, Tamaoka M, Hanazawa R, Hirakawa A, Miyazaki Y: Local nasal immunotherapy with birch pollen-galactomannan conjugate-containing ointment in mice and humans. Allergol Int, 2023 Nov 17:S1323-8930(23)00111-9. doi: 10.1016/j.alit.2023.10.007.

*Tokyo Medical and Dental University,

Oba S*, Hosoya T, Kaneshige R, Kawata1 D, Yamaguchi T, Mitsumura T, Shimada S, Shibata S, Tateishi T, Koike R, Tohda S, Hirakawa A, Nukui Y, Otomo Y, Nojima J, Miyazaki Y, Yasuda S: Thrombosis and antiphospholipid antibodies in Japanese COVID-19: based on propensity score matching. Front Immunol, 14:1227547, 2023

*Tokyo Medical and Dental University

Honda T*, Seto K, Endo S, Takemoto A, Tanimoto K, Kobayashi M, Kitano M, Sakakibara R, Mitsumura T, Ishibashi H, Inazawa J, Tanaka T, Miyazaki Y, Okubo K: The possibility of mutations of RAS signaling genes and/or TP53 in combination as a negative prognostic impact on pathological stage I non-small cell lung cancer. Cancer Med, 12(19):19406-19413,2023

*Tokyo Medical and Dental University

Aoki H*, Miyazaki Y, Anzai T, Yokoyama K, Tsuchiya J, Shirai T, Shibata S, Sakakibara R, Mitsumura T, Honda T, Furusawa H, Okamoto T, Tateishi T, Tamaoka M, Yamamoto M, Takahashi K, Tateishi U, Yamaguchi T. Deep convolutional neural network for differentiating between sarcoidosis and lymphoma based on [18F]FDG maximum‑intensity projection images. European Radiology 34:374–383,2024 doi: 10.1007/s00330-023-09937-x

*Tokyo Medical and Dental University

Omori M*, Minegishi Y, Uruga H, Fukuizumi A, Isobe K, Izumi S, Koyama R, Bando M, Sugiyama H, Takahashi K, Gemma A, Homma S, Sugiyama Y, Kishi K: Carboplatin and weekly paclitaxel in combination with bevacizumab for the treatment of advanced non-small cell lung cancer complicated by idiopathic interstitial pneumonias: A feasibility study. Respir Investig, 61(5):625-631,2023　doi: 10.1016/j.resinv.2023.06.002.

*Nippon Medical School

Kataoka K*, Oda K, Takizawa H, Ogura T, Miyamoto A, Inoue Y, Akagawa S, Hashimoto S, Kishaba T, Sakamoto K, Hamada N, Kuwano K, Nakayama M, Ebina M, Enomoto N, Miyazaki Y, Atsumi K, Izumi S, Tanino Y, Ishii H, Ohnishi H, Suda T, Kondoh Y: Cohort study to evaluate prognostic factors in idiopathic pulmonary fibrosis patients introduced to oxygen therapy. Sci Rep 13(1):13664 ,2023

doi: 10.1038/s41598-023-40508-8. PMID: 37608014; PMCID: PMC10444790.

*Tosei General Hospital

Maruyama S*, Furusawa H, Endo S, Kumagai T, Mitsumura T, Shimada S, Yamana T, Sakakibara R, Iijima Y, Shibata S, Honda T, Shirai T, Okamoto T, Tateishi T, Tamaoka M, Kinowaki Y, Ishibashi H, Okubo K, Miyazaki Y： Pulmonary artery aneurysm in a patient with nontuberculous mycobacteria infection. Intern Med, 2023 Aug 9.

doi: 10.2169/internalmedicine.2199-23.

*Tokyo Medical and Dental University

Fujita Y*, Fujimoto S, Miyamoto A, Kaneko R, Kadota T, Watanabe N, Kizawa R, Kawamoto H, Watanabe J, Utsumi H, Wakui H, Minagawa S, Araya J, Ohtsuka T, Ochiya T, Kuwano K: Fibroblast-derived extracellular vesicles induce lung cancer progression in the idiopathic pulmonary fibrosis microenvironment. Am J Respir Cell Mol Biol, 69(1):34-44, 2023　doi: 10.1165/rcmb.2022-0253OC. PMID:36848313.

*The Jikei University School of Medicine

Takada K, Ogawa K, Miyamoto A, Nakahama H, Moriguchi S, Murase K, Hanada S, Takaya H, Tamaoka M, Takai D: Risk factors and interventions for developing recurrent pneumonia in older adults. ERJ Open Res. 9(3):00516-2022,2023

doi: 10.1183/23120541.00516-2022. PMID: 37143835

Iwata S*, Hanada S, Takata M, Morozumi M, Kamei S, Ubukata K; Pneumococcal Meningitis Surveillance Study Group: Risk factors and pathogen characteristics associated with unfavorable outcomes among adults with pneumococcal meningitis in Japan, 2006 to 2016. J Infect Chemother. 29(7):637-645,2023

doi: 10.1016/j.jiac.2023.03.003. Epub 2023 Mar 11.　PMID: 36907551

* National Cancer Center Hospital; Keio University School of Medi

Tateishi T*, Shimada S, Yamana T, Iijima Y, Sakakibara R, Mitsumura T, Shibata S, Honda T, Shirai T, Okamoto T, Tamaoka M, Sasai T, Miyazaki Y: COVID-19 Pneumonia followed by anti-signal recognition particle antibody-positive fibrosing interstitial lung disease. Intern Med, 62(9):1323-1328,2023 　doi: 10.2169/internalmedicine.8877-21.

*Tokyo Medical and Dental University

Okuda R*, Ogura T, Hisata S, Baba T, Kondoh Y, Suda T, Johkoh T, Iwasawa T, Tomioka H, Bando M, Azuma A, Inoue Y, Arai T, Nakamura Y, Miyamoto A, Miyazaki　Y, Chiba H, Ishii H, Hamada N, Terasaki Y, Kuwahira I, Sato S, Kato S, Suzuki T,Sakamoto S, Nishioka Y, Hattori N, Hashimoto N, Morita S, Ichihara N, Miyata H, Hagiwara K, Nukiwa T, Kobayashi K: Design and rationale of the Japanese idiopathic interstitial pneumonias (JIPS) registry. Respir Investig. 61(1):95-102,2023 doi: 10.1016/j.resinv.2022.08.009. Epub 2022 Nov 15. PMID:36580379.

* Kanagawa Cardiovascular and Respiratory Center

村瀬享子, 中濱洋, 宮本篤, 宇留賀公紀, 藤井丈士, 玉岡明洋, 高井大哉：気管支鏡検査で器質化肺炎と診断された加湿器肺の1例．ｱﾚﾙｷﾞｰ、72(3):295-299,2023　DOI：10.15036/arerugi.72.295

中濱洋, 森口修平:Stenotrophomonas maltophiliaによる感染性肺嚢胞の1 例. 日本気胸・嚢胞性肺疾患学会雑誌、23:6-10,2023

丸山総一*, 岡本師, 柴田翔, 本多隆行, 白井剛, 古澤春彦, 立石知也, 玉岡明洋, 宮崎泰成：進行性線維化を伴う間質性肺疾患におけるﾆﾝﾃﾀﾞﾆﾌﾞ投与量の違いによる安全性と有効性．呼吸臨床7(4): 1/8-8/8　2023.04

*東京医科歯科大学 呼吸器内科

Endo　S*, Honda　T, Kawahara T, Sakakibara R, Mitsumura T, Okamoto T, Miyazaki Y, Profile of metastatic lung cancer patients susceptible to development of thromboembolism during immunotherapy. Cancer Treatment and Research Communications 31: 100547, 2022 doi: 10.1016/j.ctarc.2022.100547

*Tokyo Medical and Dental University

Sakashita H*, Uchibori K, Jin Y, Tsutsui T, Honda T, Sakakibara R, Mitsumura T, Nukui Y, Shirai T, Masuo M, Suhara K, Furusawa H, Yamashita Y, Ohba T, Saito K, Takagiwa J, Miyashita Y, Inase N, Miyazaki Y, A phase II feasibility study of carboplatin and nab-paclitaxelfor advanced non-small cell lung cancer patients with interstitiallung disease (YLOG0114). Thorac Cancer. 13:1267–1275, 2022.

*Tokyo Medical and Dental University

Aoyagi Y*, Kano Y, Tohyama K, Matsudera S, Kumaki Y, Takahashi K, Mitsumura T, Harada Y, Sato A, Nakamura H, Sueoka E, Aragane N, Kimura K, Onishi I, Takemoto A, Akahoshi K, Ono H, Ishikawa T, Tokunaga M, Nakagawa T, Oshima N, Nakamura R, Takagi M, ,Asakage T, Uetake H, Tanabe M, Miyake S, Kinugasa Y, Ikeda S, Clinical uility of comprehensive genomic profiling in Japan: Result of PROFILE-F study. PLoS One 31;17(3):e0266112, 2022.0 doi: 10.1371/journal.pone.0266112.

*Tokyo Medical and Dental University

Okuda R*, Ogura T, Hisata S, Baba T, Kondoh Y, Suda T, Johkoh T, Iwasawa T, Tomioka H, Bando M, Azuma A, Inoue Y, Arai T, Nakamura Y, Miyamoto A, Miyazaki Y, Chiba H, Ishii H, Hamada N, Terasaki Y, Kuwahira I, Sato S, Kato S, Suzuki T, Sakamoto S, Nishioka Y, Hattori N, Hashimoto N, Morita S, Ichihara N, Miyata H, Hagiwara K, Nukiwa T, Kobayashi K :Design and rationale of the Japanese Idiopathic Interstitial Pneumonias (JIPS) Registry. Respir Investig. 2023 Jan;61(1):95-102. doi: 10.1016/j.resinv.2022.08.009. Epub 2022 Nov 15. PMID:36580379.
*Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center

Miyamoto A, Michimae H, Nakahara Y, Akagawa S, Nakagawa K, Minegishi Y, Ogura T, Hontsu S, Date H, Takahashi K, Homma S, Kishi K: Chemotherapy versus best supportive care in advanced lung cancer and idiopathic interstitial pneumonias: A retrospective multi-centre cohort study.; Investigators Group for Lung Cancer and IIP. Respir Investig. 2022 Dec 7:S2212-5345(22)00151-4. doi: 10.1016/j.resinv.2022.10.009.
PMID: 36496345

Mitsumura T*, Okamoto T, Tosaka M, Yamana T, Shimada S, Iijima Y, Sakakibara R, Shibata S, Honda T, Shirai T, Ishizuka M, Aiboshi J, Furusawa H, Tateishi T, Tamaoka M, Shigemitsu H, Arai H, Otomo Y, Tohda S, Anzai T, Takahashi K, Yasuda S, Miyazaki Y: Association of SARS-CoV-2 RNA Copy Number with the COVID-19 Mortality Rate and Its Effect on the Predictive Performance of Mortality in Severe Cases. Jpn J Infect Dis. 2022 Sep 22;75(5):504-510.
*Department of Respiratory Medicine, Tokyo Medical and Dental University

Nakahama H, Hanada S, Takada K, Ishikawa N, Hirata N, Moriguchi S, Murase K, Miyamoto A, Fujii T, Ubukata K, Kishi K, Takai D, Tamaoka M: Obstructive pneumonia caused by Gordonia bronchialis with a bronchial foreign body. Int J Infect Dis. 2022 Nov; 124:157-158
doi: 10.1016/j.ijid.2022.09.028. Epub 2022 Sep 21. PMID: 36152956.

Aoyama Y, Miyamoto A, Fujii T, Fujimori S, Tamaoka M, Takai D: Primary bronchial schwannoma: A case report. Medicine (Baltimore). 2022 Oct 7; 101(40):e31062. 2022
doi: 10.1097/MD.0000000000031062. PMID: 36221358; PMCID:PMC9542747.

Komatsu M*, Yamamoto H, Matsui S, Terasaki Y, Hebisawa A, Iwasawa T, Johkoh T, Baba T, Miyamoto A, Handa T, Tomii K, Waseda Y, Bando M, Ishii H, Miyazaki Y, Yoshizawa A, Takemura T, Kawabata Y, Hanaoka M, Ogura T; Tokyo Diffuse Lung Disease Study Group: Respiratory lesions in IgG4-related disease: classification using 2019 American College of Rheumatology/European League Against Rheumatism criteria. ERJ Open Res. 2022 Sep 12;8(3):00120-2022.
doi:10.1183/23120541.00120-2022. PMID: 36105152; PMCID: PMC9465005.
*First Department of Internal Medicine, Shinshu University School of Medicine

Komatsu M*, Yamamoto H, Uehara T, Kobayashi Y, Hozumi H, Fujisawa T, Miyamoto A, Kishaba T, Kunishima F, Okamoto M, Kitamura H, Iwasawa T, Matsushita S, Terasaki Y, Kunugi S, Ushiki A, Yasuo M, Suda T, Hanaoka M:Prognostic implication of IgG4 and IgG1-positive cell infiltration in the lung in patients with idiopathic interstitial pneumonia. Sci Rep. 2022 Jun 3;12(1):9303. doi: 10.1038/s41598-022-13333-8. PMID: 35661786 Free PMC article.
*First Department of Internal Medicine, Shinshu University School of Medicine

Ozawa S, Hanada S, Uruga H, Ito H, Nakahama H, Ishikawa N, Moriguchi S, Murase K, Miyamoto A, Hayashi N, Takai D: Disseminated cryptococcosis in a renal transplant recipient. Respirol Case Rep. 2022 Jul 31;10(9):e01011.
doi:10.1002/rcr2.1011. PMID: 35923712; PMCID: PMC9339528. 2022 Jul 31

Murakami T*, Iijima Y, Ando T, Ejima M, Shirai T, Furusawa H, Okamoto T, Tateishi T, Tamaoka M, Miyazaki Y: Successful diagnosis of humidifier lung by individual provocation test to a responsible environment, a case report. Respir Med Case Rep. 2022 Mar 22;37:101639.
*Department of Respiratory Medicine, Tokyo Medical and　Dental University

Hanada S, Takata M, Morozumi M, Iwata S, Fujishima S, Ubukata K; Invasive Pneumococcal Diseases Surveillance Study Group: Multiple comorbidities increase the risk of death from invasive pneumococcal disease under the age of 65 years. J Infect Chemother. 27:1311-1318、2021
doi: 10.1016/j.jiac.2021.04.018. Epub 2021 May 4.

Komatsu M*, Yamamoto H, Matsui S, Terasaki Y, Hebisawa A, Iwasawa T, Johkoh T, Baba T, Miyamoto A, Handa T, Tomii K, Waseda Y, Bando M, Ishii H, Miyazaki Y, Yoshizawa A, Takemura T, Kawabata Y, OguraT and the Tokyo Diffuse Lung Disease Study Group: Clinical characteristics of immunoglobulin G4-positive interstitial pneumonia. ERJ Open Res 2021; 7: 00317-2021
* First Dept of Internal Medicine, Shinshu University School of Medicine

Nakashima S, Miyamoto A, Takahashi Y, Nakahama H, Moriguchi S, Murase K, Morokawa N, Takai D: Mendelson's syndrome complicated by bacterial aspiration pneumonia triggered by right putamen bleeding: A case report. Respir Med Case 33:101466,2021 doi: 10.1016/j.rmcr.2021.101466.

Yotsumoto T*, Maemura K, Watanabe K, Amano Y, Matsumoto Y, Zokumasu K, Ando T, Kawakami M, Kage H, Nakajima J, Yatomi Y, Nagase T, Takai D: NRXN1 as a novel potential target of antibody-drug conjugates for small cell lung cancer. Oncotarget, 29;11(39):3590-3600,2020
*The University of Tokyo Graduate School of Medicine

Kadota T*, Yoshioka Y, Fujita Y, Araya J, Minagawa S, Hara H, Miyamoto A,Suzuki S, Fujimori S, Kohno T, Fujii T, Kishi K, Kuwano K, Ochiya T: Extracellular vesicles from fibroblasts induce epithelial-cell senescence in pulmonary fibrosis. Am J Respir Cell Mol Biol. 63(5):623-636,2020
*National Cancer Center Research Institute

Takada K, Miyamoto A, Nakahama H, Moriguchi S, Takahashi Y, Ogawa K, Murase K, Hanada S, Morokawa N, Kurosaki A, Fujii T, Hasegawa E, Takaya H, Takai D: Myeloperoxidase anti-neutrophil cytoplasmic antibody-associated vasculitis with a unique imaging presentation of organizing pneumonia: A case report. Respir Med Case Rep. 31:101294,2020

Ogawa K, Uruga H, Fujii T, Fujimori S, Kohno T, Kurosaki A, Kishi K, Abe S: Characteristics of non-small-cell lung cancer with interstitial pneumonia: variation in cancer location, histopathology, and frequency of postoperative acute exacerbations in interstitial pneumonia. BMC Pulm Med. 20(1):307,2020

Kasai T*, Mori K, Kishi K, Kaburagi T, Hosomi Y, Imai H, Yamada Y, Yomota M, Moriguchi S, Seike M, Minato K, Gemma A: A phase I and extension study of S-1 and carboplatin for previously untreated patients aged 75 years or more with advanced non-small cell lung cancer -TCOG 1101. Int J Clin Oncol. 25(5):867-875,2020
*Tochigi Cancer Center

Tateishi K*, Ko R, Shukuya T, Okuma Y, Watanabe S, Kuyama S, Murase K, Tsukita Y, Ashinuma H, Nakagawa T, Uematsu K, Nakao M, Mori Y, Kaira K, Mouri A, Miyabayashi T, Sakashita H, Matsumoto Y, Tanigawa T, Koizumi T, Morita S, Kobayashi K, Nukiwa T, Takahashi K: Clinical Outcomes of Second-Line Chemotherapy in Patients with Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023 Study. Oncologist.　25(4):e668-e674,2020
*Shinshu University School of Medicine

Uruga H, Fujii T, Nakamura N, Moriguchi S, Kishi K, Takaya H: Squamous cell transformation as a mechanism of acquired resistance to tyrosine kinase inhibitor in EGFR-mutated lung adenocarcinoma: a report of two cases. Respirol Case Rep. 8(2):e00521,2020

Tashiro M*, Takazono T, Saijo T, Yamamoto K, Imamura Y, Miyazaki T, Kakeya H, Ando T, Ogawa K, Kishi K, Tokimatsu I, Hayashi Y, Fujiuchi S, Yanagihara K, Miyazaki Y, Ichihara K, Mukae H, Kohno S, Izumikawa K: Selection of oral antifungals for initial maintenance therapy in chronic pulmonary aspergillosis: A longitudinal analysis. Clin Infect Dis. 70(5):835-42,2020
*Nagasaki University Graduate School of Biomedical Sciences

Mikami Y*, Jo T, Matsuzaki H, Ishimori T, Saito M, Sakamoto Y, Yamauchi Y, Takai D, Yatomi Y, Nagase T: Preoperative intervention with long-acting bronchodilators for the reduction of postoperative pulmonary complications in untreated patients with obstructive lung disease. Clin Respir J. 14(2):92-101,2020
*The University of Tokyo

Ando T*, Kage H, Matsumoto Y, Zokumasu K, Yotsumoto T, Maemura K, Amano Y, Watanabe K, Nakajima J, Nagase T, Takai D: Integrin α11 in non-small cell lung cancer is associated with tumor progression and postoperative recurrence. Cancer 111(1):200-208,2020
*The University of Tokyo